Insider Trading February 13, 2026

Mitsui Sumitomo Makes $2.8 Million Run of Purchases in W.R. Berkley Stock

Transactions executed under a Rule 10b5-1 plan raise the insurer’s direct holding to 56.6 million shares as W.R. Berkley posts mixed fourth-quarter results and approves a 9-cent dividend

By Marcus Reed WRB
Mitsui Sumitomo Makes $2.8 Million Run of Purchases in W.R. Berkley Stock
WRB

Mitsui Sumitomo Insurance Co. Ltd., a roughly 10% holder of W.R. Berkley Corp. (WRB), purchased $2.8 million of common stock across multiple trades on February 12-13, 2026 under a pre-arranged Rule 10b5-1 plan adopted in October 2025. The purchases spanned prices between $69.7349 and $72.7573 and increase the company’s direct stake to 56,596,652 shares. Separately, W.R. Berkley reported fourth-quarter 2025 revenue that exceeded expectations while earnings per share matched forecasts, and declared a regular quarterly cash dividend of $0.09 per share payable March 4, 2026 to holders of record on February 23, 2026.

Key Points

  • Mitsui Sumitomo purchased $2.8 million in W.R. Berkley common stock across multiple trades on February 12-13, 2026 under a Rule 10b5-1 plan.
  • The purchase prices ranged from $69.7349 to $72.7573; after the transactions the buyer directly holds 56,596,652 Berkley shares.
  • W.R. Berkley reported Q4 2025 revenue above expectations, EPS in line with forecasts, and declared a $0.09 per share quarterly dividend payable March 4, 2026.

Mitsui Sumitomo Insurance Co. Ltd. disclosed purchases of common stock in W.R. Berkley Corp. (NYSE: WRB) totaling $2.8 million, according to a Form 4 filed with the Securities and Exchange Commission. The company, identified in the filing as a roughly 10% owner of Berkley, executed multiple transactions on February 12 and February 13, 2026.

The trades occurred under a pre-established Rule 10b5-1 purchase plan that Mitsui Sumitomo adopted on October 3, 2025. The filing details the individual transactions and price ranges for each lot purchased.

On February 12, the insurer bought 17,599 shares at a weighted average price of $71.8808, with execution prices in that lot running from $71.4623 to $72.46. The same day it acquired an additional 2,401 shares at a weighted average of $72.7573, with execution prices between $72.465 and $73.0501.

Activity continued on February 13, when Mitsui Sumitomo purchased 15,406 shares at a weighted average price of $69.7349, with individual prices in that lot ranging from $69.3373 to $69.9996. It also bought 4,314 shares at a weighted average of $70.2977, with prices from $70.00 to $70.9521, and a smaller lot of 280 shares at a weighted average price of $71.1840, with prices spanning $71.0038 to $71.5014.

After these purchases settled, the filing reports Mitsui Sumitomo directly holds 56,596,652 shares of W.R. Berkley common stock. The filing does not provide further commentary from the buying party beyond confirming the trades were made pursuant to the previously adopted 10b5-1 plan.


Separately noted in the filing and related disclosures, W.R. Berkley reported fourth-quarter 2025 results in which the company’s revenue came in ahead of expectations while earnings per share were in line with analyst forecasts. The company also declared a regular quarterly cash dividend of $0.09 per share on its common stock, scheduled to be paid on March 4, 2026 to shareholders of record as of February 23, 2026.

These corporate disclosures together document recent insider activity by a large institutional shareholder, contemporaneous quarterly financial results, and a dividend commitment. The Form 4 provides a transaction-by-transaction record of the purchases, their timing, and price ranges, and the company’s earnings release and dividend notice supply the reported operational and shareholder-return details recorded for the fourth quarter of 2025.

Risks

  • The Form 4 details purchases executed under a pre-arranged 10b5-1 plan, which reflects pre-specified trading arrangements rather than new, discretionary purchases - this limits interpretation of motive or future intent.
  • Market price movements could affect the value of the newly acquired shares between execution and settlement; the filing records price ranges but does not address settlement risk.
  • The company’s Q4 results show a mixed picture - revenue beat while EPS matched forecasts - which could create uncertainty for investors assessing near-term performance in the insurance sector.

More from Insider Trading

Clean Harbors Director Executes $204,802 Sale as Company Reports Strong Q4 and Pushes M&A Agenda Feb 21, 2026 Clean Harbors Executive Disposes Nearly $1.0M in Stock as Company Posts Strong Q4 Feb 21, 2026 Clean Harbors CFO Disposes $784K in Shares as Company Reports Strong Quarter and Pursues Acquisition Feb 21, 2026 Travelers Executive Vice President Records $1.74 Million Share Sale as Company Posts Strong Quarter Feb 21, 2026 Genasys Director Buys $50,404 of Stock; Company Reports Mixed Q1 Results Feb 21, 2026